Create a free account to see ACCE Scores
Sign up for free to unlock scores, score breakdowns, and stock analysis.
CTNM
↓ PDF (Pro)Contineum Therapeutics Inc. Class A Common Stock
HealthcareBiotechnologyUnited StatesNASDAQ
$14.31
+1.13%today
MKT CAP
$562M
+11.1% · 1Y
Earnings History
-8.8%
-50.6%
+1.6%
-26.1%
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Analyst Targets
Current price
$14.31
Low
$14.00
Analyst Mean
$22.17
High
$29.00
6 analystsStrong Buy
Full Financials
Trailing P/E-
Forward P/E-7.4x
EV/EBITDA-
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ-
5y Revenue CAGR-
5y Earnings CAGR-
Gross Margin-
Operating Margin-
Net Margin-
ROE-
Debt / Equity-
Free Cash Flow-
Insider Ownership1.0%
Institutional Ownership93.2%
Short % of Float10.16%
Days to Cover8.4d
1 Week+13.8%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
| Filer | Role | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| LORRAIN DANIEL S. PH.D. | Officer | Sale | 4,170 | $13.06 | $0.05M | 2026-05-01 |
| LORRAIN DANIEL S. PH.D. | Officer | Sale | 4,170 | $13.43 | $0.06M | 2026-04-06 |
| WATKINS TIMOTHY M.D. | Officer | Conversion | 3,611 | $4.50 | $0.02M | 2026-03-02 |
| LORRAIN DANIEL S. PH.D. | Officer | Sale | 4,170 | $15.01 | $0.06M | 2026-03-02 |
| WATKINS TIMOTHY M.D. | Officer | Sale | 3,611 | $15.02 | $0.05M | 2026-03-02 |
Top Holders
| Holder | Type | % Held | Value | Δ Shares | As of |
|---|---|---|---|---|---|
| Suvretta Capital Management, LLC | institution | 8.68% | $0.04B | +65.19% | 2025-12-31 |
| Janus Henderson Group PLC | institution | 7.48% | $0.04B | +100.00% | 2025-12-31 |
| RA Capital Management, L.P. | institution | 6.66% | $0.03B | +2.72% | 2025-12-31 |
| Johnson & Johnson | institution | 6.05% | $0.03B | +0.00% | 2025-12-31 |
| Franklin Resources, Inc. | institution | 5.74% | $0.03B | +13.52% | 2025-12-31 |
| Balyasny Asset Management LP | institution | 5.63% | $0.03B | +93.71% | 2025-12-31 |
| Perceptive Advisors Llc | institution | 4.48% | $0.02B | +104.95% | 2025-12-31 |
| Baker Bros. Advisors, LP | institution | 4.34% | $0.02B | +1729.33% | 2025-12-31 |
| Vanguard Group Inc | institution | 3.88% | $0.02B | +31.80% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | fund | 2.78% | $0.01B | +40.62% | 2025-12-31 |
| Millennium Management Llc | institution | 2.54% | $0.01B | +28.58% | 2025-12-31 |
| Franklin Strategic Series-FRANKLIN BIOTECHNOLOGY DISCOVERY FUND | fund | 2.07% | $0.01B | +16.12% | 2026-01-31 |
| Fidelity Select Portfolios-Select Health Care Portfolio | fund | 1.38% | $0.01B | +0.00% | 2026-02-28 |
| Fidelity Advisor Series VII-Fidelity Advisor Health Care Fund | fund | 0.86% | $0.00B | +0.00% | 2026-02-28 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | fund | 0.62% | $0.00B | +8.43% | 2025-12-31 |
| iShares Trust-iShares Biotechnology ETF | fund | 0.61% | $0.00B | +6.74% | 2026-03-31 |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | fund | 0.30% | $0.00B | -0.36% | 2026-02-28 |
| SCHWAB STRATEGIC TRUST-Schwab U.S. Small-Cap ETF | fund | 0.28% | $0.00B | +11.04% | 2026-02-28 |
| Variable Insurance Products Fund IV-VIP Health Care Portfolio | fund | 0.24% | $0.00B | +0.00% | 2026-02-28 |
| iShares Trust-iShares Micro-Cap ETF | fund | 0.19% | $0.00B | +35.67% | 2026-03-31 |
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Recent Alerts
No alerts yet for CTNM.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.